When was NeuroPlus founded?

NeuroPlus was founded in 2011 and raised its 1st funding round 3 years after it was founded.

Where is NeuroPlus located?

NeuroPlus is headquartered in Durham, United States.

Who is the current CEO of NeuroPlus?

Jake Stauch of NeuroPlus. They have also founded 1 company.

How many employees does NeuroPlus have?

As of Aug 31, 2026, the latest employee count at NeuroPlus is 15.

Is NeuroPlus a funded company?

NeuroPlus is a funded company, having raised a total of $999K across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 01, 2014.

When was the latest funding round of NeuroPlus?

NeuroPlus' latest funding was a $***** Seed round on May 01, 2018, with participation from 0 investor. Its primary sector is Wearable Technology. In United States, the Wearable Technology sector has seen $1.25B in funding in 2026 to date.

Where does NeuroPlus rank among its competitors?

NeuroPlus ranks 44th amongst 412 active competitors, of which 89 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was BrainCo, which secured an undisclosed amount in Sep, 2026.

Who are the top competitors of NeuroPlus?

NeuroPlus' top competitors include Muse, Flow Neuroscience and Apollo Neuroscience. Among them, BrainCo secured the most recent funding round in September, 2026.

NeuroPlus - 2026 Company Profile, Team, Funding & Competitors

NeuroPlus is a seed company based in Durham (United States), founded in 2011 by Jake Stauch. It operates as a Game-based application for training attention skills. NeuroPlus has raised $999K in funding. The company has 412 active competitors, including 89 funded and 11 that have exited. Its top competitors include companies like Muse, Flow Neuroscience and Apollo Neuroscience.

Company Details

Neuro+ is a digital health company that provides a system to train for attention and focus on brain-controlled video games for children and adults. The company offers a brain-sensing connected headband, that monitors the brain activity while playing the game. The company claims that the solution helps in reducing inattentiveness, hyperactivity, and impulsivity. The program is targeted to be used by clinicians and schools to help adults and children struggling with neurological problems like ADHD.

Website: neuro.plus
Social
Email ID: *****@neuro.plus
Phone Number: +1 **********

Key Metrics

Founded Year

2011

Location

Durham, United States

Stage

Seed

Total Funding

$999K in 2 rounds

Latest Funding Round

Seed, May 01, 2018, $*****

Investors

Triangle Angel Partners & 1 more

Ranked

44^th among 412 active competitors

Employee Count

15 as on Aug 31, 2026

Similar Companies

BrainCo & 437 more

View NeuroPlus' full profile

NeuroPlus is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
NeuroPlus Inc. CIN: 453503611 , United States, Active		-	-	-

NeuroPlus has raised a total funding of $999K over 2 rounds. Its first funding round was on Jul 01, 2014. NeuroPlus has 2 institutional investors.

Here is the list of recent funding rounds of NeuroPlus:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 01, 2018	9466944	Seed	1597180	9230676	9878019	4647731
Jul 01, 2014	6321861	Seed	7793876	6862261	9558687	Capital A Partners

Access funding benchmarks and valuations. Sign up today!

View details of NeuroPlus's funding rounds and investors

The founders of NeuroPlus is Jake Stauch.

Here are the details of NeuroPlus' key team members:

Jake Stauch: Founder & CEO of NeuroPlus and founder of 1 other company.

View details of NeuroPlus's Founder profiles and Board Members

NeuroPlus' employee count trend

NeuroPlus has 15 employees as of Aug 26. Here is NeuroPlus's employee count trend over the years:

Uncover NeuroPlus' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NeuroPlus include Muse, Flow Neuroscience and Apollo Neuroscience. Here is the list of Top 10 competitors of NeuroPlus, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Muse 2007, Toronto (Canada), Series C	Provider of brainwave tracking devices and related premium subscription services	$57.4M	OMERS, Export Development Canada & 22 others	63/100
2nd	Flow Neuroscience 2016, Malmo (Sweden), Series A	Provider of a wearable device for stress and anxiety management	$11.9M	Khosla Ventures, HAX & 6 others	61/100
3rd	Apollo Neuroscience 2017, Pittsburgh (United States), Series A	Developer of wearable technology for stress reduction, sleep improvement, and performance enhancement	$30.7M	Noetic Psychedelic Fund, Republic Capital ... & 9 others	61/100
4th	Hapbee 2004, Phoenix (United States), Public	Retailer of wearable technology products designed to improve sleep and wellness	$4.8M	Smile Group, Incisive Ventures	60/100
5th	BrainCo 2015, Somerville (United States), Series B	Provider of a prosthetic hand and EEG headband for brain signal	$292M	Walden International, IDG Capital & 10 others	58/100
6th	Mave Health 2023, Bengaluru (India), Seed	Provider of NIBS wearable device designed to improve brain health	$2.85M	Blume Venture, iSeed & 34 others	58/100
7th	TeachTown 2001, Woburn (United States), Acquired	Provider of SaaS-based educational software and solutions for students with autism and related disorders	$12.8M	Bain Capital Double Impact, ED & 1 others	58/100
8th	Rethink 2007, New York City (United States), Series D	Web-based educational and personalized behavior therapy to children and employee benefit solutions	$16.7M	Seavest Investment Group, Arboretum Ventures ... & 7 others	58/100
9th	Parallel 2021, New York City (United States), Series B	Provider of virtual special education services for schools	$48.9M	Valspring Capital, Tiger Global Management ... & 12 others	57/100
10th	NeuroSigma 2008, Los Angeles (United States), Seed	Develops and commercializes trigeminal nerve stimulation (TNS) devices for treatment of psychiatric disorders	$2.92M	Checkmate Capital, NINDS & 2 others	57/100
44th	NeuroPlus 2011, Durham (United States), Seed	Game-based application for training attention skills	$999K	Triangle Angel Partners, Capital A Partners	39/100